Additional Information
Market: LSE
Sector: General Financial
EPIC: UKX
Latest Price: 5,351.50p  (0.03% Ascending)
52-week High: 6,084.10p
52-week Low: 4,791.00p
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
HB Markets
www.hbmarkets.com

HB Markets is an award winning stockbroker and who offer share dealing services for private clients, experienced investors and companies. HB Markets specialise in the small cap sector.

These are flash views from HB Markets and are not investment advice. Please ensure that you have read and understood the risk warnings below or by clicking here.

Pdf

Hoodless Brennan Daily Small Cap News Flash including Synchronica, Media Corp, Iomart, Watermark, Rheochem and more

1st Sep 2009, 3:12 pm Hoodless Brennan Daily Small Cap News Flash including Synchronica, Media Corp, Iomart, Watermark, Rheochem and more

You can receive this report by email in the morning by clicking here.

Media Corporation (MDC, 1.125p, £2.99m) Trading update for the second half confirms an improvement in trading combined with lower costs. Eyeconomy has seen a strong Q3 with sales up 18% on Q2 and a healthy start to Q4 with a good order pipeline. Publishing is seeing good growth in its leading sites of spert.co.uk, onthebox.com and gambling.com, the latter could benefit from any relaxation of the US gaming laws. With the group still expected to report a loss for the year, with cash being consumed the shares rate a HOLD.

 

Watermark (WET, 0.75p, £5.09m) Interims to June 2009 confirms the Definitive Feasibility Study for its acid mine draining scheme will be completed by the end of September, a few weeks later than planned. The Environmental Impact Assessment will also be completed by the end of September. With a range of milestones over the next 4 months that could drive the price higher, the shares remain a SPECULATIVE BUY.

Get this report in the morning

White Young Green (WHY, 12p, £6.36m) Has announced a deferral of its covenant test till the end of September, ahead of its finals which are to be released in mid October. HOLD till the outcome of the talks with the danger of a share issue is known.

 

Iomart (IOM, 45p, £43.63m) Has partnered with Cimex, a digital marketing agency, to provide a disaster recovery solution for a number of high profile Government related sites, such as the Department of Children, Schools & Families, Department of Health, Department for Culture, Media and Sports, The Learning Council, the Gambling commission, the National Lottery and the COI, the UK’s largest advertiser. Forecasts to March 2010 are for £1.3m pre-tax profits with 1.3p EPS followed by £3m with 2.9p EPS, putting the group on prospective PER’s of 34.6x followed by 15.5x. Well up with events. HOLD.

Get this report in the morning

Pursuit Dynamics (PDX, 141.75p, £87m) The appointment of a CEO, Joel Pieper, who appears to have no relevant experience, his background is in software, does not bode well for PDX. We last recommended the group as a Speculative Buy at 79p on 30 June 2009, take the profits, SELL.

 

Synchronica (SYNC, 3.375p, £19.49m) Has won a contract with a Pakistani mobile operator for an initial 50,000 user license worth US$ 121,500 together with professional services worth $29,750. The scope for growth with the operator is significant as it has more than 20m subscribers in its network. 

Get this report in the morning

Rheochem (RHEP, 6.375p, £13.84m) Interims to June 2009 saw oilfield revenues rise from Aus$23.8m to a record Aus$34.4m with an underlying pre-tax profit of Aus$6.6m (Aus$8.4m). However the figures were heavily distorted by one-offs, such as a downward valuation of Aus$23.4m on its venture capital, leading to a distorted revenue reported at Aus$10.9m, a Aus$29.6m write-off on its oil & gas assets and Aus$6.6m goodwill impairment write-off-leading to a reported pre-tax loss of Aus$48.2m (profit Aus$5.8m). However the drilling fluids operation did well with a number of new clients signed, including the majors, and a number of coal-bed methane operations that typically drill significantly more holes than oil & gas exploration businesses. The outlook is strong with the recovery in the oil price for the year lows underlining exploration activity and increased contributions expected from Rheochem’s Australasian and Indian operations. The heavy write-offs in the oil & gas trading and venture capital investments reflect a major review and change of its major interest from an investment into a 50% subsidiary following a default by the key shareholder in the assets. In a major change the investment operation, Zeus, will relinquish a number of properties, but will still retain assets of 2.97mm of 2P reserves in the Athena field, North Sea block 14/11 with a potential of 93m barrels in which it is seeking farm-in partners and 90% in Block 14.26b including the Thunderball discovery. The group has warned of a claim for some £8m from a drilling company that has been lodged with Zeus –though it hasn’t gone to court yet. The impact of the write-downs has been to reduce the NAV to some Aus$32.6m (£16.75m). The group consumed cash (as we would expect with an exploration business and growth operation) and so feel the rating is appropriate given the discount to NAV. The share is above our year price target so investors should now regard the share as a HOLD.

 

Scott Wilson (SWG, 88.75p, £64.79m) AGM statement has highlighted continued strong demand in some sectors, such as road and rail (UK and overseas) with a number of major projects secured. Elsewhere the private commercial sector remains depressed with little signs of a recovery in the short-term. The overseas success, including gaining contracts on the Hong Kong MTR and road/rail projects in Poland, Serbia & Mozambique, lead the board to confidence in meeting the expectations for the current year. Forecasts around £17m pre-tax profits with 15p EPS to May 2010 put the group on a 5.9x prospective PER and so we repeat our BUY recommendation last iterated on 29/06/09 at 65.75p, with a maintained 100p price target.

Get this report in the morning

MDM Engineering (MDM, 167p, £62.22m) Has won a scoping study for Rand Uranium to examine the potential from reprocessing gold and uranium tailings. Forecasts to March 2010 are for pre-tax profits of £4.4m with 8.6p EPS followed by £8.8m with 16.64p EPS, putting the group on prospective PERs of 19.4x down to 10x the following year. Well up with events, HOLD.

 

Pilat Media Global (PGB, 25.25p, £14.95m), the supplier of business management software to the media industry globally, released interims results to the end of June 2009. Sales were up 1.8% to £8.3m (H108: £8.18m) and the group reduced operating losses to £0.104m from £0.888m. Weak sterling has had a negative impact on the group’s overall losses for the year.

 

Hoodless Brennan view: Pilat’s management team believe they will report a profit at the end of 2009. With high level of seasonality in H2, especially in the final quarter, we are sceptical as to whether this will be achieved or not. There is a risk that certain contracts may not fall in the current financial year. The group is debt free and cash generative. HOLD

Get this report in the morning

HB MARKETS DISCLOSURES

  1. The analyst may have a personal holding of the securities issued by the company, or of derivatives related to such securities.
  2. HB Markets or an affiliate may own more than 5% of the issued capital of the company.
  3. HB Markets or an affiliate may be party to an agreement with the company relating to the provision of corporate broking services, or has been party to such an agreement within the last 12 months. Our corporate broking agreements include a provision that we will prepare and publish research at such times as we consider appropriate.
  4. HB Markets or an affiliate may have been a lead manager or co-lead manager of a publicly disclosed offer of securities for the company within the last 12 months
  5. HB Markets may be a market maker or liquidity provider in the securities issued by the company

Please check with our advisers 020 7382 8300 if you are concened with the above material interests prior to acting upon this information.

RISK WARNING NOTICE

All investments are speculative and prices may change quickly and go down as well as up. Past performance will not necessarily be repeated and is no guarantee of future s uccess. There is an extra risk of losing money when shares are bought in some smaller companies including “penny shares”. There can be a big difference between the buying price and the sel ling price of these shares and if they have to be sold immediately, you may get back much less than you paid for them or in some circumstances, it may be difficult to sell at any price. It may also be difficult for you to obtain reliable information about the value of this investment or the extent of the risks to which it is exposed. Where a company has chosen to borrow money (gearing) as part of its business strategy its share price may become more volatile and subject to sudden and large falls. This investment may not be suitable for all investors, and clients should carefully consider their own personal financial circumstances before dealing in the stock market, particularly those on fixed incomes or approaching retirement age. If you have any doubts you should seek advice from your investment adviser or your broker at this firm.

AIM: The Alternative Investment Market (AIM) is market designed primarily for emerging or smaller companies. The rules of this market are less demanding than those of the official List of the London Stock Exchange and therefore companies quoted on AIM carry a greater risk than a company with a full listing.

MATERIAL INTEREST

We endeavour at all times to ensure that our research is clear, fair and not misleading, however, we do not hold our research out as being impartial and it should not be v iewed as wholly objective since HB Markets (including its parent company and its subsidiaries, their directors, officers or employees) may have or previously held a material intere st in the company which is the main subject matter of the research note, or any other company mentioned, and may be providing or have provided within the previous 12 months significant advice or investment services in relation to any company or a related company referred to in this document, or any other associated document. This document has been prepared and issued by HB Markets on the basis of publicly available information, internally developed data and other sources believed to be reliable. Whilst all reasonable care is taken to ensure that the facts stated are accurate and the opinions given are fair and reasonable, neither HB Markets nor any director, officer or employee shall in any way be responsible for its contents. This document is intended to provide clients with information and should not be construed as an offer or solicitation to buy or sell securities.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.